{"entity":{"type":"insider","cik":"0001559509","url":"/insider/0001559509","json_url":"/insider/0001559509.json","name":"SAPIRSTEIN JAMES","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":10,"first":"2015-11-24","last":"2024-07-03","span_basis":"filed_date"},"name_variants":[{"name":"SAPIRSTEIN JAMES","source":"filing","n_filings":10,"first_seen":"2015-11-24","last_seen":"2024-07-03"}],"transactions":[{"id":2284592,"accession":"0001104659-24-077713","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-077713","line_url":"/filing/0001104659-24-077713#line-1","is_derivative":false,"issuer_cik":"0001559509","issuer_name":"Entero Therapeutics, Inc.","issuer_ticker":"ENTO","issuer_name_source":null,"issuer_url":"/issuer/0001559509","owner_cik":"0001559509","owner_name":"SAPIRSTEIN JAMES","owner_display_name":"SAPIRSTEIN JAMES","owner_url":"/insider/0001559509","role":"Director, Officer (Chairman and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1289.0,"shares_display":"1,289","price_per_share":1.07,"price_display":"1.07","price_state":"stated","total_value":1379.23,"total_display":"1,379.23","total_whole":"1,379","shares_owned_after":35816.0,"shares_owned_after_display":"35,816","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-07-02","filed_date":"2024-07-03","scope":"insider"},{"id":2998371,"accession":"0001104659-24-043156","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-043156","line_url":"/filing/0001104659-24-043156#line-1","is_derivative":false,"issuer_cik":"0001559509","issuer_name":"First Wave BioPharma, Inc.","issuer_ticker":"FWBI","issuer_name_source":null,"issuer_url":"/issuer/0001559509","owner_cik":"0001559509","owner_name":"SAPIRSTEIN JAMES","owner_display_name":"SAPIRSTEIN JAMES","owner_url":"/insider/0001559509","role":"Director, Officer (Chairman and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":174.0,"shares_display":"174","price_per_share":4.2294,"price_display":"4.23","price_state":"stated","total_value":735.9156,"total_display":"735.92","total_whole":"736","shares_owned_after":37105.0,"shares_owned_after_display":"37,105","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-01","filed_date":"2024-04-03","scope":"insider"},{"id":2128959,"accession":"0001104659-24-036143","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-036143","line_url":"/filing/0001104659-24-036143#line-1","is_derivative":false,"issuer_cik":"0001559509","issuer_name":"First Wave BioPharma, Inc.","issuer_ticker":"FWBI","issuer_name_source":null,"issuer_url":"/issuer/0001559509","owner_cik":"0001559509","owner_name":"SAPIRSTEIN JAMES","owner_display_name":"SAPIRSTEIN JAMES","owner_url":"/insider/0001559509","role":"Director, Officer (Chairman and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1887.0,"shares_display":"1,887","price_per_share":4.96,"price_display":"4.96","price_state":"stated","total_value":9359.52,"total_display":"9,359.52","total_whole":"9,360","shares_owned_after":37279.0,"shares_owned_after_display":"37,279","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-15","filed_date":"2024-03-19","scope":"insider"},{"id":2907123,"accession":"0001104659-24-004458","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-004458","line_url":"/filing/0001104659-24-004458#line-1","is_derivative":false,"issuer_cik":"0001559509","issuer_name":"First Wave BioPharma, Inc.","issuer_ticker":"FWBI","issuer_name_source":null,"issuer_url":"/issuer/0001559509","owner_cik":"0001559509","owner_name":"SAPIRSTEIN JAMES","owner_display_name":"SAPIRSTEIN JAMES","owner_url":"/insider/0001559509","role":"Director, Officer (Chairman, President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chairman, President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":166.0,"shares_display":"166","price_per_share":4.2,"price_display":"4.20","price_state":"stated","total_value":697.2,"total_display":"697.20","total_whole":"697","shares_owned_after":39166.0,"shares_owned_after_display":"39,166","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-01-12","filed_date":"2024-01-17","scope":"insider"},{"id":8073330,"accession":"0001104659-23-107481","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-107481","line_url":"/filing/0001104659-23-107481#line-1","is_derivative":false,"issuer_cik":"0001559509","issuer_name":"First Wave BioPharma, Inc.","issuer_ticker":"FWBI","issuer_name_source":null,"issuer_url":"/issuer/0001559509","owner_cik":"0001559509","owner_name":"SAPIRSTEIN JAMES","owner_display_name":"SAPIRSTEIN JAMES","owner_url":"/insider/0001559509","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2764.0,"shares_display":"2,764","price_per_share":0.29,"price_display":"0.29","price_state":"stated","total_value":801.56,"total_display":"801.56","total_whole":"802","shares_owned_after":33397.0,"shares_owned_after_display":"33,397","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-10-04","filed_date":"2023-10-06","scope":"insider"},{"id":7803978,"accession":"0001104659-23-078144","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-078144","line_url":"/filing/0001104659-23-078144#line-1","is_derivative":false,"issuer_cik":"0001559509","issuer_name":"First Wave BioPharma, Inc.","issuer_ticker":"FWBI","issuer_name_source":null,"issuer_url":"/issuer/0001559509","owner_cik":"0001559509","owner_name":"SAPIRSTEIN JAMES","owner_display_name":"SAPIRSTEIN JAMES","owner_url":"/insider/0001559509","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3349.0,"shares_display":"3,349","price_per_share":1.54,"price_display":"1.54","price_state":"stated","total_value":5157.46,"total_display":"5,157.46","total_whole":"5,157","shares_owned_after":36161.0,"shares_owned_after_display":"36,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-07-03","filed_date":"2023-07-05","scope":"insider"},{"id":8533870,"accession":"0001104659-23-042156","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-23-042156","line_url":"/filing/0001104659-23-042156#line-1","is_derivative":false,"issuer_cik":"0001559509","issuer_name":"First Wave BioPharma, Inc.","issuer_ticker":"FWBI","issuer_name_source":null,"issuer_url":"/issuer/0001559509","owner_cik":"0001559509","owner_name":"SAPIRSTEIN JAMES","owner_display_name":"SAPIRSTEIN JAMES","owner_url":"/insider/0001559509","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3347.0,"shares_display":"3,347","price_per_share":2.5,"price_display":"2.50","price_state":"stated","total_value":8367.5,"total_display":"8,367.50","total_whole":"8,368","shares_owned_after":39510.0,"shares_owned_after_display":"39,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-03","filed_date":"2023-04-05","scope":"insider"},{"id":2547537,"accession":"0001104659-16-097943","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-16-097943","line_url":"/filing/0001104659-16-097943#line-1","is_derivative":false,"issuer_cik":"0001559509","issuer_name":"ContraVir Pharmaceuticals, Inc.","issuer_ticker":"CTRV","issuer_name_source":null,"issuer_url":"/issuer/0001559509","owner_cik":"0001559509","owner_name":"SAPIRSTEIN JAMES","owner_display_name":"SAPIRSTEIN JAMES","owner_url":"/insider/0001559509","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":1.0,"price_display":"1.00","price_state":"stated","total_value":10000.0,"total_display":"10,000.00","total_whole":"10,000","shares_owned_after":13000.0,"shares_owned_after_display":"13,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-18","filed_date":"2016-02-18","scope":"insider"},{"id":8789385,"accession":"0001104659-15-082199","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-082199","line_url":"/filing/0001104659-15-082199#line-1","is_derivative":false,"issuer_cik":"0001559509","issuer_name":"ContraVir Pharmaceuticals, Inc.","issuer_ticker":"CTRV","issuer_name_source":null,"issuer_url":"/issuer/0001559509","owner_cik":"0001559509","owner_name":"SAPIRSTEIN JAMES","owner_display_name":"SAPIRSTEIN JAMES","owner_url":"/insider/0001559509","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":2.15,"price_display":"2.15","price_state":"stated","total_value":1075.0,"total_display":"1,075.00","total_whole":"1,075","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-30","filed_date":"2015-12-01","scope":"insider"},{"id":8899243,"accession":"0001104659-15-081123","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-15-081123","line_url":"/filing/0001104659-15-081123#line-1","is_derivative":false,"issuer_cik":"0001559509","issuer_name":"ContraVir Pharmaceuticals, Inc.","issuer_ticker":"CTRV","issuer_name_source":null,"issuer_url":"/issuer/0001559509","owner_cik":"0001559509","owner_name":"SAPIRSTEIN JAMES","owner_display_name":"SAPIRSTEIN JAMES","owner_url":"/insider/0001559509","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":1.64,"price_display":"1.64","price_state":"stated","total_value":4100.0,"total_display":"4,100.00","total_whole":"4,100","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-11-23","filed_date":"2015-11-24","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":7,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001604191","name":"Entero Therapeutics, Inc.","url":"/issuer/0001604191","role":"Director, Officer (Chairman and CEO)","n_filings":7,"first_seen":"2023-04-05","last_seen":"2024-07-03"},{"type":"issuer","type_label":"ISSUER","cik":"0001583771","name":"ContraVir Pharmaceuticals, Inc.","url":"/issuer/0001583771","role":"Director, Officer (Chief Executive Officer)","n_filings":3,"first_seen":"2015-11-24","last_seen":"2016-02-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001559509","retrieved_at":"2026-08-23T08:50:53+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}